Statement of the Spanish interdisciplinary vascular prevention committee on the updated European cardiovascular prevention guidelines

P Armario, C Brotons, R Elosua… - Clínica e Investigación …, 2021 - Elsevier
We present the adaptation for Spain of the updated European Cardiovascular Prevention
Guidelines. In this update, greater stress is laid on the population approach, and especially …

Effects of hypertension on cancer survival: a meta‐analysis

F Petrelli, A Ghidini, M Cabiddu… - European Journal of …, 2021 - Wiley Online Library
Background Hypertension is usually associated with increased cardiovascular mortality.
Uncertainty exists about the possible role of hypertension as a poor prognostic factor for …

[HTML][HTML] Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020

D Orozco-Beltrán, CB Cuixart, JJA Sánchez… - Atención Primaria, 2020 - Elsevier
The recommendations of the semFYC's Program for Preventive Activities and Health
Promotion (PAPPS) for the prevention of cardiovascular diseases (CVD) are presented. The …

Prevalence, awareness, treatment, and control of hypertension based on ACC/AHA versus JNC7 guidelines in the PERSIAN cohort study

S Sepanlou, F Najafi, H Poustchi, M Parsaeian… - Scientific reports, 2022 - nature.com
In this cross-sectional population-based study, we used the baseline data of the Prospective
Epidemiologic Research Studies in IrAN cohort study collected in Iran from 2014 to 2020 …

Hypertension: The most common chronic health problem in Spain. A call to action

JR Banegas, T Gijón-Conde - Hipertensión y Riesgo Vascular, 2022 - Elsevier
Hypertension (HYP) is the first cause of death and disability worldwide. In Spain, one in 3
adults was hypertensive in 2010 (62% in those> 65 years in 2017). Despite improvement in …

[HTML][HTML] Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2022

D Orozco-Beltrán, CB Cuixart, JRB Banegas… - Atención Primaria, 2022 - Elsevier
The recommendations of the semFYC's Program for Preventive Activities and Health
Promotion (PAPPS) for the prevention of cardiovascular diseases (CVD) are presented. The …

Stage 1 hypertension by the 2017 American College of Cardiology/American Heart Association hypertension guidelines and risk of cardiovascular disease events …

M Han, Q Chen, L Liu, Q Li, Y Ren, Y Zhao… - Journal of …, 2020 - journals.lww.com
Background: Epidemiological studies reported an inconsistent association between stage 1
hypertension (SBP 130–139 mmHg or DBP 80–89 mmHg) defined by the 2017 American …

Renal dysfunction among rheumatoid arthritis patients: A retrospective cohort study

AO Oweis, KM Alawneh, SA Alshelleh… - Annals of Medicine …, 2020 - journals.lww.com
Background: Rheumatoid arthritis (RA) is a common rheumatological disease which can
involve a variety of different renal manifestations. This may be explained by disease effect …

Cifras e impacto de la hipertensión arterial en España

JR Banegas, MS Martínez, TG Conde, EL García… - Revista Española de …, 2024 - Elsevier
In Spain, 33% of adults aged 30 to 79 years (10 million) were hypertensive in 2019. Among
them, 68% were diagnosed, 57% received drug therapy, and effective therapeutic coverage …

Clinical characteristics, treatment, and blood pressure control in patients with hypertension seen by primary care physicians in Spain: the IBERICAN study

MA Prieto-Díaz, V Pallares-Carratala… - Frontiers in …, 2023 - frontiersin.org
Objectives To determine the clinical profile, according to the history of hypertension, the risk
of developing hypertension, current antihypertensive treatment and BP control rates in …